相关实验视频
Updated: Jul 15, 2025

08:28
Single-molecule Manipulation of G-quadruplexes by Magnetic Tweezers
Published on: September 19, 2017
8.0K
通过BODIPY G-quadruplex稳定剂重新编程癌细胞
Aminesena Baser1, Beyza Basar2,3, Hanim Beyza Dogan1
1Konya Food and Agriculture University, Beysehir Cd. No: 9 Meram, Konya, Turkey.
概括
一种新型的阴离体 BODIPY 稳定剂向G-四重复DNA,显著减少癌细胞入侵和调节转移相关基因. 这种G-quadruplex稳定剂对小分子抗癌疗法有前途.
科学领域:
- 药用化学 医学化学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 越来越多的G-四重复结构被认为是癌症中潜在的治疗点.
- 开发选择性小分子来稳定G-四重复DNA是一种有前途的抗癌策略.
- 癌细胞迁移和入侵是转移中的关键过程,需要调节.
研究的目的:
- 开发和表征一种基于体的分子,具有选择性的G-四重复稳定性.
- 评估G-quadruplex稳定剂在抑制癌细胞迁移和入侵方面的有效性.
- 研究稳定剂对基因表达和与转移相关的细胞代谢的影响.
主要方法:
- 合成和表征一个阴阳性BODIPY衍生物.
- G-四重复结合亲和性和选择性测试 (例如,使用光谱学).
- 在体外测试以评估癌细胞迁移和入侵.
- 定量PCR (qPCR) 用于测量转移相关基因 (HIF1α,VIM,CDH1) 的表达.
- 测量氧气消耗率以分析细胞代谢.
主要成果:
- 一种基于体的G-四重复稳定剂成功开发出来.
- 稳定剂显著抑制了癌细胞迁移和入侵 (高达90%).
- 观察到关键转移相关基因 (HIF1α,VIM,CDH1) 的调节.
- 该化合物重新编程了缺氧适应性新陈代谢,导致O2消耗增加1.82倍,恢复正常的能量新陈代谢.
- 具有高G-四重复性亲和度 (Kd = 0.38 μM) 的稳定剂显示出显著的抗癌作用.
结论:
- 基于体的G-四重复稳定剂在抑制癌细胞转移方面有效.
- 这些稳定剂通过调节基因表达和细胞代谢,为向癌症提供了一种新的方法.
- 开发的G-quadruplex稳定剂代表了开发小分子抗癌药物的有希望的候选人.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Restarting Stalled Replication Forks
5.8K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.8K

